MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities,short-term$126,980K Cash and cashequivalents$12,360K Prepaid expenses andother current assets$2,913K Other receivables$1,904K Contract assets$1,006K Accounts receivable$69K Total current assets$145,232K Operating lease, right ofuse assets$17,670K Property and equipment,net$6,760K Marketable securities,long-term$3,505K Other assets$2,200K Total assets$175,367K Total liabilities andstockholders equity$175,367K Total stockholdersequity$122,175K Total liabilities$53,192K Accumulated deficit-$596,515K Additionalpaid-in-capital$718,578K Operating leaseliabilities, non-current$26,026K Total currentliabilities$25,414K Deferred revenue, net ofcurrent portion (0 and...$1,752K Accumulated othercomprehensive income$103K Common stock, par value0.0001 per share,...$9K Accrued expenses andother current...$16,535K Accounts payable$5,783K Deferred revenue (0 and2,487 from related...$1,895K Operating leaseliabilities, current$1,201K
Balance Sheet
source: myfinsight.com

Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences, Inc. (CRBU)